Furthermore, CCR7+ICOS+ memory Tfh cells may play a crucial role in the autoimmune inflammation lesions in the CNS and may serve as a new biomarker for evaluating the disease activity and severity in patients with relapsed MS. The gene discussed is CCR7; the disease is myeloid sarcoma.